Literature DB >> 24952365

β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers.

Andrea Myers1, William T Barry2, Michelle S Hirsch3, Ursula Matulonis1, Larissa Lee4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24952365     DOI： 10.1016/j.ygyno.2014.06.010

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  20 in total

1.  Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Andrea P Myers; Virginia L Filiaci; Yuping Zhang; Michael Pearl; Kian Behbakht; Vicky Makker; Parviz Hanjani; Susan Zweizig; James J Burke; Gordon Downey; Kimberly K Leslie; Paul Van Hummelen; Michael J Birrer; Gini F Fleming
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

2.  Proteogenomic Characterization of Endometrial Carcinoma.

Authors:  Yongchao Dou; Emily A Kawaler; Daniel Cui Zhou; Marina A Gritsenko; Chen Huang; Lili Blumenberg; Alla Karpova; Vladislav A Petyuk; Sara R Savage; Shankha Satpathy; Wenke Liu; Yige Wu; Chia-Feng Tsai; Bo Wen; Zhi Li; Song Cao; Jamie Moon; Zhiao Shi; MacIntosh Cornwell; Matthew A Wyczalkowski; Rosalie K Chu; Suhas Vasaikar; Hua Zhou; Qingsong Gao; Ronald J Moore; Kai Li; Sunantha Sethuraman; Matthew E Monroe; Rui Zhao; David Heiman; Karsten Krug; Karl Clauser; Ramani Kothadia; Yosef Maruvka; Alexander R Pico; Amanda E Oliphant; Emily L Hoskins; Samuel L Pugh; Sean J I Beecroft; David W Adams; Jonathan C Jarman; Andy Kong; Hui-Yin Chang; Boris Reva; Yuxing Liao; Dmitry Rykunov; Antonio Colaprico; Xi Steven Chen; Andrzej Czekański; Marcin Jędryka; Rafał Matkowski; Maciej Wiznerowicz; Tara Hiltke; Emily Boja; Christopher R Kinsinger; Mehdi Mesri; Ana I Robles; Henry Rodriguez; David Mutch; Katherine Fuh; Matthew J Ellis; Deborah DeLair; Mathangi Thiagarajan; D R Mani; Gad Getz; Michael Noble; Alexey I Nesvizhskii; Pei Wang; Matthew L Anderson; Douglas A Levine; Richard D Smith; Samuel H Payne; Kelly V Ruggles; Karin D Rodland; Li Ding; Bing Zhang; Tao Liu; David Fenyö
Journal:  Cell       Date:  2020-02-13       Impact factor: 41.582

3.  Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.

Authors:  Marisa R Moroney; Kurtis D Davies; Adam C Wilberger; Jeanelle Sheeder; Miriam D Post; Amber A Berning; Christine Fisher; Carolyn Lefkowits; Saketh R Guntupalli; Kian Behbakht; Bradley R Corr
Journal:  Gynecol Oncol       Date:  2019-03-22       Impact factor: 5.482

4.  Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping.

Authors:  Yuexin Liu; Russell R Broaddus; Wei Zhang
Journal:  Expert Rev Anticancer Ther       Date:  2014-12-12       Impact factor: 4.512

5.  FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.

Authors:  Paul Weisman; Kay J Park; Jin Xu
Journal:  Int J Gynecol Pathol       Date:  2022-03-01       Impact factor: 2.762

Review 6.  Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials.

Authors:  Helen J MacKay; Douglas A Levine; Victoria L Bae-Jump; Daphne W Bell; Jessica N McAlpine; Alessandro Santin; Gini F Fleming; David G Mutch; Kenneth P Nephew; Nicolas Wentzensen; Paul J Goodfellow; Oliver Dorigo; Hans W Nijman; Russell Broaddus; Elise C Kohn
Journal:  Oncotarget       Date:  2017-08-03

7.  CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.

Authors:  Katherine C Kurnit; Grace N Kim; Bryan M Fellman; Diana L Urbauer; Gordon B Mills; Wei Zhang; Russell R Broaddus
Journal:  Mod Pathol       Date:  2017-03-10       Impact factor: 7.842

Review 8.  Wnt Signaling in Gynecologic Malignancies.

Authors:  Alexandra McMellen; Elizabeth R Woodruff; Bradley R Corr; Benjamin G Bitler; Marisa R Moroney
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

9.  Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.

Authors:  Grace Kim; Katherine C Kurnit; Bojana Djordjevic; Charanjeet Singh; Mark F Munsell; Wei-Lien Wang; Alexander J Lazar; Wei Zhang; Russell Broaddus
Journal:  Mod Pathol       Date:  2018-05-24       Impact factor: 7.842

Review 10.  Clinical actionability of molecular targets in endometrial cancer.

Authors:  Mary Ellen Urick; Daphne W Bell
Journal:  Nat Rev Cancer       Date:  2019-08-06       Impact factor: 60.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.